Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 824 across all filing types
Latest filing 2013-10-28 Regulatory Filings
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Other Report or Announcement
Regulatory Filings
2013-10-28 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is very short (1979 characters) and explicitly states it is an 'Amended report for distorted report sent on date : 23/10/2013'. Crucially, it attaches a file named '*KMDA_Form_6-K_A__Interest_Payment_isa.pdf*' and mentions 'Attached hereto is a report on'. This structure—announcing the publication of an attached/linked report rather than containing the full content of a major filing like a 10-K or IR—fits the definition of a Report Publication Announcement (RPA). Although it relates to an interest payment (which might suggest IRAT), the primary function of this specific document is the announcement/amendment of the report's release, making RPA the most accurate classification based on the 'MENU VS MEAL' rule.
2013-10-28 English
Other Report or Announcement
Regulatory Filings
2013-10-23 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is very short (under 2,000 characters) and explicitly states that it is an 'Amended report for distorted report' and that an attachment is present: 'Attached hereto is a report on *����� �� ����� ����� ��"�* *KMDA_Form_6K__Interest_Payment___October_2013_isa.pdf*'. This structure—an announcement referencing an attached, specific report (in this case, related to an Interest Payment, likely a Form 6-K filing component)—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content is purely an announcement about the publication of a specific document rather than the content of the report itself, RPA is the most precise fit, as it signals the release of a report. Given the context of regulatory filings (mentioning ISA and TASE), RNS is also plausible, but RPA specifically covers the act of publishing a report.
2013-10-23 English
Other Report or Announcement
Regulatory Filings
2013-10-08 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is very short (1587 characters) and explicitly states, "Attached hereto is a report on *[filename.pdf]*". This structure indicates that the document itself is an announcement about the publication of another report, rather than the full report content. The filing is made to the Israel Securities Authority and Tel Aviv Stock Exchange, and it is categorized as an 'Other Report or Announcement' under Regulation 5 for a foreign corporation. Since it is an announcement of a report being attached/published, and it doesn't fit specific categories like DIV, ER, or 10-K, the most appropriate classification based on the 'MENU VS MEAL' rule is Report Publication Announcement (RPA).
2013-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.